Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOX1 | Q9Y5S8 | 2/20 | 0.58 |
| ▸ | MAPT | P10636 | 8/20 | 0.48 |
| ▸ | GAA | P10253 | 6/20 | 0.48 |
| ▸ | MEN1 | O00255 | 6/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.48 |
| ▸ | HPGD | P15428 | 3/20 | 0.48 |
| ▸ | RAB9A | P51151 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | GFER | P55789 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.43 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.43 |
| ▸ | SENP7 | Q9BQF6 | 2/20 | 0.42 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1005100 | 1.00 | NOX1 (0.58) | NOX1MAPTGAAMEN1KMT2A | |
| SCHEMBL3074599 | 1.00 | NOX1 (0.58) | NOX1MAPTGAAMEN1KMT2A | |
| SCHEMBL11831353 | 0.98 | NOX1 (0.56) | NOX1MAPTGAAMEN1KMT2A | |
| SCHEMBL11831344 | 0.98 | NOX1 (0.56) | NOX1MAPTGAAMEN1KMT2A | |
| SCHEMBL16111932 | 0.79 | NOX1 (0.62) | NOX1MAPTGAAMEN1KMT2A | |
| SCHEMBL16111930 | 0.79 | NOX1 (0.62) | NOX1MAPTGAAMEN1KMT2A | |
| SCHEMBL13109406 | 0.79 | NOX1 (0.62) | NOX1MAPTGAAMEN1KMT2A | |
| SCHEMBL765856 | 0.78 | GAA (0.52) | MAPTGAAMEN1KMT2AALDH1A1 | |
| SCHEMBL14438098 | 0.76 | MAPT (0.50) | MAPTGAAMEN1KMT2AALDH1A1 | |
| SCHEMBL1002645 | 0.76 | NOX1 (0.34) | NOX1MAPTGAAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4410457-A | EPOXY REACTIVE SOLVENT, EPOXY RESIN, LATENT HARDENER, EPOXIDE-DIALKYLAMINE ADDUCT | SUMITOMO CHEMICAL CO., LTD. (JP) | 1983-10-18 | — | — | US | claimed |
| US-20260009142-A1 | Electrochemical synthesis of pyrazolines and pyrazoles | BAYER AG (DE) | 2026-01-08 | — | — | US | disclosed |
| EP-4555128-A1 | ELECTROCHEMICAL SYNTHESIS OF PYRAZOLINES AND PYRAZOLES | Bayer Aktiengesellschaft (DE) | 2025-05-21 | — | — | EP | disclosed |
| CN-119698496-A | Electrochemical synthesis of pyrazolines and pyrazoles | 拜耳公司 | 2025-03-25 | — | — | CN | disclosed |
| WO-2025003282-A2 | ATP PRODUCTION FROM ELECTRICITY WITH A NEW-TO-NATURE ELECTROBIOLOGICAL MODULE | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2025-01-02 | — | — | WO | disclosed |
| EP-4484566-A1 | ATP PRODUCTION FROM ELECTRICITY WITH A NEW-TO-NATURE ELECTROBIOLOGICAL MODULE | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2025-01-01 | — | — | EP | disclosed |
| WO-2024012791-A1 | ELECTROCHEMICAL SYNTHESIS OF PYRAZOLINES AND PYRAZOLES | BAYER AKTIENGESELLSCHAFT (DE) | 2024-01-18 | — | — | WO | disclosed |
| US-11851391-B2 | Antifungal compounds and methods of forming the same | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2023-12-26 | — | — | US | disclosed |
| EP-3828179-A1 | CYANOPYRROLIDINES AS DUB MODULATORS | Mission Therapeutics Limited (GB) | 2021-06-02 | — | — | EP | disclosed |
| US-20200024224-A1 | ANTIFUNGAL COMPOUNDS AND METHODS OF FORMING THE SAME | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION | 2020-01-23 | — | — | US | disclosed |
| CN-1041084-A | Edible fungus inoculation method | LI YUNLONG (CN) | 1990-04-11 | — | — | CN | disclosed |
| EP-0274114-A2 | Heat curable organopolysiloxane compositions | Wacker Silicones Corporation (US) | 1988-07-13 | — | — | EP | disclosed |
| US-4725628-A | Process of making a crosslinked superabsorbent polyurethane foam | KIMBERLY-CLARK CORPORATION (US) | 1988-02-16 | — | — | US | disclosed |
| US-4710559-A | Heat curable organopolysiloxane compositions | WACKER SILICONES CORPORATION (US) | 1987-12-01 | — | — | US | disclosed |
| EP-0039230-B1 | CURABLE COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1985-12-11 | — | — | EP | disclosed |
| US-4410457-A | EPOXY REACTIVE SOLVENT, EPOXY RESIN, LATENT HARDENER, EPOXIDE-DIALKYLAMINE ADDUCT | SUMITOMO CHEMICAL CO., LTD. (JP) | 1983-10-18 | — | — | US | disclosed |
| US-4360649-A | EPOXY RESIN, EPOXIDE-DIALKYLAMINE ADDUCT, UREA COMPOUND, CURING AGENTS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1982-11-23 | — | — | US | disclosed |
| EP-0039230-A2 | Curable composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1981-11-04 | — | — | EP | disclosed |
| US-4172835-A | URINARY ANTISEPTIC, HYPOTENSIVE AGENT AND HYPOGLYCEMIC AGENT | STERLING DRUG INC. (US) | 1979-10-30 | — | — | US | disclosed |
| US-3948939-A | 9-Acyl-1,2,3,4-tetrahydrocarbazole-3 and 4-carboxylic acids | STERLING DRUG INC. (US) | 1976-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260009142-A1 | Electrochemical synthesis of pyrazolines and pyrazoles | CYP2E1, CYP2F1, CYP4F2 | NOX1 280/4885MAPT 4836/4885GAA 3100/4885 |
| US-11851391-B2 | Antifungal compounds and methods of forming the same | DPM1, ERG28, SUCLG1 | NOX1 151/4885MAPT 1403/4885GAA 202/4885 |
| US-20200024224-A1 | ANTIFUNGAL COMPOUNDS AND METHODS OF FORMING THE SAME | DPM1, ERG28, SUCLG1 | NOX1 151/4885MAPT 1403/4885GAA 202/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.